NPR1 and ovarian carcinoma: Using an animal model, wild-type and NPR-A-deficient C57BL/6 mice were injected with ovarian cancer cells and monitored weekly for tumor growth; by week 8, all mice from the wild-type group developed solid tumors, but no tumors were observed in NPR-A-deficient mice[8].